publication . Article . 2017

Insulin resistance in drug naive patients with multiple sclerosis

Kostić Smiljana; Kolić Ivana; Raičević Ranko; Stojanović Zvezdana; Kostić Dejan; Dinčić Evica;
Open Access
  • Published: 01 Jan 2017
  • Country: Serbia
Background/Aim. Due to the fact that there is a relatively small number of data related to systemic insulin abnormalities in the multiple sclerosis (MS), the main objective of our study was to determine whether a dysbalance of glucose and insulin metabolism exist in patients with natural course of MS. Our hypothesis was that the metabolic disorder that characterizes state of the insulin resistance (IR) and reduced insulin sensitivity (IS) in untreated patients with MS could play a role in disease progression and degree of functional disability. Methods. The study included 31 patients with relapsing-remitting (RR) MS and 14 healthy controls from the same geograph...
free text keywords: multiple sclerosis, insulin resistance, glucose tolerance, test, surveys and questionnaires, Glucose tolerance test, medicine.diagnostic_test, medicine, medicine.disease, Drug-naïve, medicine.drug, Surgery, medicine.medical_specialty, Endocrinology, Diabetes mellitus, Expanded Disability Status Scale, Hyperinsulinemia, Insulin, medicine.medical_treatment, Internal medicine, business.industry, business, questionnaires, Medicine (General), R5-920
43 references, page 1 of 3

1. Compston A, Coles A, Bujko K, Bujko M. Multiple sclerosis. Lancet 2008; 372(9648): 1502−17.

2. Hill JM, Lesniak MA, Pert CB, Roth J. Autoradiographic localization of insulin receptors in rat brain: Prominence in olfactory and limbic areas. Neuroscience 1986; 17(4): 1127−38. [OpenAIRE]

3. Woods SC, Seeley RJ, Baskin DG, Schwartz MW. Insulin and the blood-brain barrier. Curr Pharm Des 2003; 9(10): 795−800.

4. Heni M, Kullmann S, Preissl H, Fritsche A, Häring HU. Impaired insulin action in the human brain: Causes and metabolic consequences. Nat Rev Endocrinol 2015; 11(12): 701−11.

5. Banks WA, Illes P, Alexandre RJ. The source of cerebral insulin. Eur J Pharmacol 2004; 490(1−3): 5−12.

6. Seaquist ER, Damberg GS, Tkac I, Gruetter R. The effect of insulin on in vivo cerebral glucose concentrations and rates of glucose transport/metabolism in humans. Diabetes 2001; 50(10): 2203−9. [OpenAIRE]

7. Watson GS, Craft S. Insulin resistance, inflammation, and cognition in Alzheimer's Disease: Lessons for multiplesclerosis. J Neurol Sci 2006; 245(1−2): 21−33.

8. Yanagita T, Nemoto T, Satoh S, Yoshikawa N, Maruta T, Shiraishi S, et al. Neuronal Insulin Receptor Signaling: A Potential Target for the Treatment of Cognitive and Mood Disorders.In: Kocabasoglu N, editor. Mood disorders. Rijeka: InTech; 2013. p. 263−87. [OpenAIRE]

9. Heni M, Schöpfer P, Peter A, Sartorius T, Fritsche A, Synofzik M, et al. Evidence for altered transport of insulin across the bloodbrain barrier in insulin-resistant humans. Acta Diabetol 2014; 51(4): 679−81.

10. Russo CV, Salvatore E, Saccà F, Tucci T, Rinaldi C, Sorrentino P, et al. Insulin sensitivity and early-phase insulin secretion in normoglycemic Huntington's disease patients. J Huntingtons Dis 2013; 2(4): 501−7.

11. Schioth HB, Craft S, Brooks SJ, Frey WH, Benedict C. Brain insulin signaling and Alzheimer'sdisease: Current evidence and future directions. Mol Neurobiol 2012; 46(1): 4−10. [OpenAIRE]

12. Aviles-Olmos I, Limousin P, Lees A, Foltynie T. Parkinson's disease, insulin resistance and novel agents of neuroprotection. Brain 2013; 136(Pt 2): 374−84.

13. Edwards LJ, Constantinescu CS. A prospective study of conditions associated with multiple sclerosis in a cohort of 658 consecutive outpatients attending a multiple sclerosis clinic. Mult Scler 2004; 10(5): 575−81.

14. Wada Т, Hoshino М, Kimura Y, Ojima M, Nakano T, Koya D, et al. Both type I and II IFN induce insulin resistance by inducing different isoforms of SOCS expression in 3T3-L1 adipocytes. Am J Physiol Endocrinol Metab 2011; 300(6): 1112−23.

15. Mahler A, Steiniger J, Bock M, Brandt AU, Haas V, Boschmann M, et al. Is metabolic flexibility altered in multiple sclerosis patients. PLoS One 2012; 7(8): e43672.

43 references, page 1 of 3
Powered by OpenAIRE Open Research Graph
Any information missing or wrong?Report an Issue
publication . Article . 2017

Insulin resistance in drug naive patients with multiple sclerosis

Kostić Smiljana; Kolić Ivana; Raičević Ranko; Stojanović Zvezdana; Kostić Dejan; Dinčić Evica;